Co-Authors
This is a "connection" page, showing publications co-authored by Guizhen Wu and Baoying Huang.
Connection Strength
0.558
-
Profiles of SARS-CoV-2 RNA and Antibodies in Inpatients with COVID-19 not Related with Clinical Manifestation: A Single Centre Study. Virol Sin. 2021 10; 36(5):1088-1092.
Score: 0.060
-
Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China. Protein Cell. 2021 01; 12(1):4-6.
Score: 0.058
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 01; 21(1):39-51.
Score: 0.057
-
Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat Commun. 2020 08 06; 11(1):3910.
Score: 0.056
-
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
Score: 0.055
-
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020 07; 583(7818):830-833.
Score: 0.055
-
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020 05 29; 368(6494):1016-1020.
Score: 0.055
-
Age-related rhesus macaque models of COVID-19. Animal Model Exp Med. 2020 Mar; 3(1):93-97.
Score: 0.055
-
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 02 22; 395(10224):565-574.
Score: 0.054
-
A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 02 20; 382(8):727-733.
Score: 0.054